Loading...
FAQs
A-
A+

Fonts Size

Change Color

Hit enter to search or ESC to close
A-
A+

Fonts Size

Change Color

Alert:

20 May 2022 DoH urges all healthcare facilities operating in the emirate to be vigilant about any suspected or confirmed Monkeypox cases to find out more Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here

351

Reviewed COVID-19
Research in Abu Dhabi

305

Approved Proposals

Approved COVID-19 Research by category

Epidemiological

157

Therapeutic

42

Diagnostic

106

COVID-19 Vaccine Trials

1.

Multicenter, Randomized, Double Blind, Parallel Placebo Controlled, Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety and immunogenicity of Inactivated SARS-CoV-2 Vaccines in Healthy Population Aged 18 years old and above- Sinopham​

2.

A Phase III, Randomized, double-blind, placebo-controlled trial to evaluate Immunogenicity and Safety of the Gam-COVID-Vac combined vector vaccine in prophylactic Treatment for SARS-СoV-2 infection in the United Arab Emirates- SPUTNIK​

3.

“A Phase I/II Single-Blinded Randomised Safety and Immunogenicity Study in Adults of​ AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the​ Prevention of COVID 19- AstraZeneca​

4.

Post-Authorisation Efficacy and Safety Study (PAESS) (01_BIBP_PAESS): A Multicenter Observational Study of the Efficacy and Safety of the Inactivated SARS-CoV-2 Vaccine

5.

Post-Authorization Effectiveness and Safety Study (PAESS) (02_BIBP_PAESS): A Single Center Observational Study of the Effectiveness and Safety of the Inactivated SARS-CoV-2 Vaccine in Healthy Pediatric Population aged 3-17 years old​

6.

Clinical trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO cells) and Inactivated COVID-19 Vaccine (Vero cells) in Population aged 18 years and above.​

7.

A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Single Ascending Dose of PIKA Recombinant COVID-19 Vaccine in Healthy Adults, and Safety, Immunogenicity and Preliminary Efficacy of Multiple Ascending Doses of PIKA COVID-19 Vaccine in Adult Patients with Mild to Moderate COVID-19​

8.

A Phase III, Randomized, Double Blind, Placebo-Controlled International Multisite Clinical Trial in Parallel Assignment to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik Light Vector Vaccine in Adults in the SARS-CoV-2 Infection Prophylactic Treatment​

9.

Phase II Exploratory Clinical Trial (COVID-19-IVIG-201): A, Randomized, Double-blind, Placebo-controlled Phase II Exploratory Clinical Trial to Evaluate the Efficacy and Safety of Human COVID-19 Immunoglobulin (pH4) for Intravenous Injection in the Treatment of Patients with COVID-19​

Subscribe for updates

Thanks for Subscribing

Last updated: 30 Mar 2023

Mobile For an optimal experience please
rotate your device to portrait mode